BrainsWay Ltd. (BRSYF)
- Previous Close
2.4700 - Open
2.4700 - Bid 3.5500 x --
- Ask 48.0500 x --
- Day's Range
2.4700 - 2.4700 - 52 Week Range
1.3100 - 3.1500 - Volume
250 - Avg. Volume
9 - Market Cap (intraday)
157.163M - Beta (5Y Monthly) 0.38
- PE Ratio (TTM)
315.00 - EPS (TTM)
0.0100 - Earnings Date Nov 13, 2024 - Nov 18, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
12.00
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
www.brainsway.comRecent News: BRSYF
View More
Performance Overview: BRSYF
Trailing total returns as of 10/10/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BRSYF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BRSYF
View MoreValuation Measures
Market Cap
155.97M
Enterprise Value
110.46M
Trailing P/E
315.00
Forward P/E
34.97
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.93
Price/Book (mrq)
2.44
Enterprise Value/Revenue
3.03
Enterprise Value/EBITDA
39.68
Financial Highlights
Profitability and Income Statement
Profit Margin
1.67%
Return on Assets (ttm)
0.73%
Return on Equity (ttm)
1.44%
Revenue (ttm)
36.43M
Net Income Avi to Common (ttm)
608k
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
47.86M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
3.16M
Research Analysis: BRSYF
View MoreCompany Insights: BRSYF
BRSYF does not have Company Insights